Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nordbyhagen
Clinical trial register · Norway

Clinical Trials in Nordbyhagen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Norway and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1262 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
1262
Studies in scope
all four open statuses
667
Recruiting now
open to new participants
220
Lead sponsors
across recruiting studies
Top sites
Oslo 730 Bergen 324 Trondheim 255 Tromsø 148 Stavanger 123
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie2 Boehringer Ingelheim2 Novartis Pharmaceuticals2 Aragon Pharmaceuticals, Inc.1 Actelion1 Ostfold Hospital Trust1 University Medical Center Nijmegen1 Janssen Research & Development, LLC1 Loxo Oncology, Inc.1
Site location
Oslo730 Bergen324 Trondheim255 Tromsø148 Stavanger123 Lørenskog102 Drammen94 Kristiansand59 Ålesund57 Bodø38 Tønsberg35 Grålum33 Arendal26 Lorenskog26 Haugesund24 Gjøvik24 Skien22 Levanger22 Lillehammer17 Førde16 Sarpsborg15 Hamar14 Nordbyhagen12 Molde11 Fredrikstad11 Show all 113
All 113 locations
Target enrolment
to

Trials with a site in Nordbyhagen

12 of 1262 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Norway
Start
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
414
Nordbyhagen, Skien
2025-09-13
Recruiting
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
NCT05791630Labor Dystocia, Labor Complication, Labor Onset and Length Abnormalities, Labor (Obstetrics)--Complications
Ostfold Hospital Trust
Not applicable
23,650
Nordbyhagen, Drammen, Kristiansand, Oslo, Stavanger, Tromsø, Trondheim, Bergen
2025-04-01
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Bergen, Nordbyhagen, Oslo
2024-09-26
Active, closed
AbbVie
Phase 2
156
Nordbyhagen, Tromsø
2024-03-23
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Nordbyhagen, Oslo, Tromsø, Trondheim
2024-03-13
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Nordbyhagen, Arendal, Drammen, Oslo, Skedsmokorset, Stavanger, Tromsø
2021-11-23
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Nordbyhagen, Bergen
2021-09-20
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Nordbyhagen, Trondheim
2021-09-20
Active, closed
Actelion
Phase 3
935
Nordbyhagen, Oslo
2020-06-30
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Nordbyhagen, Oslo, Stavanger
2020-03-01
Active, closed
AbbVie
Phase 3
1,336
Gjettum, Nordbyhagen, Ålesund, Levanger
2018-04-09
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Nordbyhagen
2013-10-14
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Norwegian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-norway/city/nordbyhagen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Norway and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,262 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Nordbyhagen.

How many clinical trials are recruiting in Nordbyhagen?

4 of the 12 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nordbyhagen), 12 studies
PhaseStudiesRecruitingShare
Phase 39275%
Not applicable2216.7%
Phase 2108.3%

Most active sponsors

Lead sponsors with the most studies (Nordbyhagen)
Lead sponsorStudiesRecruiting
AbbVie20
Boehringer Ingelheim20
Novartis Pharmaceuticals21
Actelion10
Aragon Pharmaceuticals, Inc.10
Janssen Research & Development, LLC11
Loxo Oncology, Inc.10
Ostfold Hospital Trust11
University Medical Center Nijmegen11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.